Probiotics in women’s health
The human probiotics market size is anticipated to surpass USD 5 billion by 2024 owing to its increasing demand. Probiotics are used to treat Urinary tract infections, diabetes, diarrhea, vulvovaginal candidiasis, and bacterial vaginosis in women. Several in vitro and in vivo studies support the beneficial effect of some strains of lactobacilli on the restoration of the vaginal flora and the prevention of recurrent UTIs.
Related Conference of Probiotics in women’s health
August 13-14, 2024
10th International Congress on Trauma, Critical Care and Emergency Medicine
Amsterdam, Netherlands
September 26-27, 2024
19th International Conference on Virology, Emerging Diseases & vaccines
Montreal, Canada
December 02-03, 2024
7th International Conference on Antimicrobial and Antibacterial Agents
Prague, Czech Republic
December 02-03, 2024
7th International Conference on Clinical Microbiology, Virology and Infectious Diseases
Prague, Czech Republic
Probiotics in women’s health Conference Speakers
Recommended Sessions
- Microbiome
- Pediatric and Infant Health
- Pre and Probiotics futures
- Prebiotics and Diet
- Prebiotics old and new
- Probiotics in Aquaculture
- Probiotics in food security
- Synbiotic
- Food and Fermentation
- Formulations and Production
- Gut Bacteria on COVID Severity
- Gut microbiota
- Microbiota from womb to adult
- Microbiota Protection and Resilience
- New Methods and New Equipment
- Nutrition and Probiotics
- Preterm and term Newborns Probiotics
- Probiotics and COVID-19
- Probiotics in oral health and dentistry
- Probiotics in women’s health
Related Journals
Are you interested in
- Agriculture & Forest Microbiology - Microbiology 2024 (Switzerland)
- Agriculture Microbiology - Beneficial Microbes 2024 (Ireland)
- Antimicrobial Agents & Resistance - Microbiology 2024 (Switzerland)
- Applied and Environmental Science - Microbiology 2024 (Switzerland)
- Aquatic & Marine Microbiology - Microbiology 2024 (Switzerland)
- Bacteriology, Bacterial Pathogens & Associated diseases - Microbiology 2024 (Switzerland)
- Beneficial Microbes in the environment - Beneficial Microbes 2024 (Ireland)
- Biological Need of Trauma - TRAUMA 2024 (Netherlands)
- Blunt Trauma - TRAUMA 2024 (Netherlands)
- Cellular Microbiology & Systems Microbiology - Microbiology 2024 (Switzerland)
- Clinical and Neuro Virology - Virology-2024 (Canada)
- Clinical and Public Health Microbiology - Microbiology 2024 (Switzerland)
- Clinical Infections and Vaccines - Microbiology 2024 (Switzerland)
- Corona Virus - Virology-2024 (Canada)
- Critical Care in Trauma - TRAUMA 2024 (Netherlands)
- Delirium in Critical Care - TRAUMA 2024 (Netherlands)
- Ecology and Evolution of Microbe-Host Interactions - Beneficial Microbes 2024 (Ireland)
- Elderly Trauma and Critical Care - TRAUMA 2024 (Netherlands)
- Engineering Beneficial Microbes - Beneficial Microbes 2024 (Ireland)
- Environmental Microbiology (Soil Microbiology & Water Microbiology) - Microbiology 2024 (Switzerland)
- Evolution in Emergency Medicine Practices - TRAUMA 2024 (Netherlands)
- General Virology - Virology-2024 (Canada)
- HIV/AIDS and Sexually Transmitted Infections - Virology-2024 (Canada)
- Immunization and Immunotherapeutics - Virology-2024 (Canada)
- Immunobiotics - Beneficial Microbes 2024 (Ireland)
- Industrial Microbiology, Microbial Biotechnology and Future Bioindustries - Microbiology 2024 (Switzerland)
- Influenza and other Respiratory Diseases - Virology-2024 (Canada)
- Intensive Care in Trauma - TRAUMA 2024 (Netherlands)
- Marine Microbiology - Beneficial Microbes 2024 (Ireland)
- Medical Parasitology - Microbiology 2024 (Switzerland)
- Microbial Cytology, Microbial Physiology & Recombination DNA - Microbiology 2024 (Switzerland)
- Microbial Ecology and Evolution - Microbiology 2024 (Switzerland)
- Microbial Infections - Virology-2024 (Canada)
- Microbiome - Beneficial Microbes 2024 (Ireland)
- Molecular Microbiology - Microbiology 2024 (Switzerland)
- Mycology, Fungal Pathogens and Associated Diseases - Microbiology 2024 (Switzerland)
- New and Endogenous Retroviruses - Virology-2024 (Canada)
- New Technology in Trauma - TRAUMA 2024 (Netherlands)
- Novel Antiviral Therapies - Virology-2024 (Canada)
- Novel Vaccine Delivery Methods - Virology-2024 (Canada)
- Obstetric Trauma - TRAUMA 2024 (Netherlands)
- Paediatric Trauma - TRAUMA 2024 (Netherlands)
- Pathogenic Microbes in Immunology and Microbiology - Beneficial Microbes 2024 (Ireland)
- Pathogenic Microbes in Medicine and Dentistry - Beneficial Microbes 2024 (Ireland)
- Plant Pathology & Microbiology - Microbiology 2024 (Switzerland)
- Probiotics & Prebiotics - Beneficial Microbes 2024 (Ireland)
- Psychological Trauma - TRAUMA 2024 (Netherlands)
- Soil biological management - Beneficial Microbes 2024 (Ireland)
- Structural and Molecular virology - Virology-2024 (Canada)
- Transmission of Viruses - Virology-2024 (Canada)
- Transplant-Associated Viral Infections - Virology-2024 (Canada)
- Trauma & Critical Care Nursing - TRAUMA 2024 (Netherlands)
- Trauma Emergency Medicine - TRAUMA 2024 (Netherlands)
- Trauma in Nursing & Midwifery - TRAUMA 2024 (Netherlands)
- Trauma Therapy - TRAUMA 2024 (Netherlands)
- Trauma-An International Perspective - TRAUMA 2024 (Netherlands)
- Trauma-Mass Casualties Incidents - TRAUMA 2024 (Netherlands)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2024 (Canada)
- Vaccines and the Microbiome - Virology-2024 (Canada)
- Veterinary Microbiology - Microbiology 2024 (Switzerland)
- Veterinary virology - Virology-2024 (Canada)
- Viral Genetics, Evolution and Dynamics - Virology-2024 (Canada)
- Viral Immunology and Immunopathology - Virology-2024 (Canada)
- Viral Oncology - Virology-2024 (Canada)
- Viral Pathogenesis - Virology-2024 (Canada)
- Virology, Viral Pathogens and Associated Diseases - Microbiology 2024 (Switzerland)